GAK Emerges as a Preclinical DLBCL Mitotic Dependency

Company Farag Lab (academic) Event Type Peer-reviewed publication (Leukemia) Modality Small molecule target discovery Asset GAK-active compounds (preclinical) Target Cyclin G-associated kinase (GAK) Disease Area Diffuse large B-cell lymphoma Summary Previously missed peer-reviewed Leukemia paper published online November 2 identifies cyclin G-associated kinase (GAK) as…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *